TMPRSS6 and fatty liver disease: Researchers have determined that a significant decrease in hepatic steatosis, body fat, and plasma triglycerides improves glucose tolerance, insulin sensitivity, and enhanced fat lipolysis in TMPRSS6−/− mice, which provides information regarding the importance of MT2 and iron regulation in obesity [16], [19].